English
Regional settings| Spread | 0.080 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ €5,000.00 Short position overnight fee ~ €4,000.00 | -0.022099% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ €5,000.00 Short position overnight fee ~ €4,000.00 | -0.000123% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | EUR | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Netherlands | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 18.965 |
| Open | 18.905 |
| 1-Year Change | -35.4% |
| Day's Range | 18.795 - 18.965 |
Corbion NV is a company based in the Netherlands that is active in the field of biochemical ingredients. The Company's products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. It operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The Company operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.
BRIEF: For the fiscal year ended 31 December 2021, Corbion NV revenues increased 9% to EUR1.07B. Net income increased 7% to EUR78.3M. Revenues reflect Sustainable Food Solutions segment increase of 7% to EUR584.2M, Lactic Acid and Specialties segment increase of 13% to EUR312.3M, Incubator segment increase from EUR13.4M to EUR30.7M, Asia segment increase of 13% to EUR193.8M, US segment increase of 4% to EUR499.2M.
04/2009, Stock Dividend, 1 new share for every 21 shares held.
